Inaccurate Diagnosis for Anti-Psychotic Medication Use
Summary
The facility failed to identify an accurate diagnosis for the use of anti-psychotic medication for one resident. The resident, a female with a history of dementia, anxiety disorder, bipolar disorder, and schizoaffective disorder, was admitted and readmitted from an acute care hospital. The Minimum Data Set (MDS) assessment indicated she was moderately cognitively impaired and did not show indicators of psychosis or behavioral symptoms. Despite this, the resident was prescribed high-risk anti-psychotic, anti-anxiety, and hypnotic medications. The comprehensive care plan included a diagnosis of schizoaffective disorder, which was not supported by the psychiatrist's notes or assessments, leading to a discrepancy in the resident's medical record and care plan. The Director of Nursing (DON) explained that behavioral health meetings were conducted monthly to discuss residents' psychiatric plans of care, including medication dose reductions and appropriate diagnoses. However, the DON admitted that the diagnosis of schizoaffective disorder was used based on hospital records and was not revised to reflect the facility's psychiatrist's assessments. The MDS Lead Coordinator confirmed that the psychiatric diagnoses were auto-populated from the electronic medical record and should be verified with the most recent physician's notes. Upon review, it was found that the psychiatrist's notes did not include a diagnosis of schizophrenia or schizoaffective disorder, contradicting the MDS and care plan. Interviews with the facility's psychiatrist revealed that he rarely used the diagnosis of schizoaffective disorder and confirmed that the resident was treated for bipolar disorder and grief. The facility's standards and guidelines emphasized the importance of accurate and timely comprehensive care plans, which should be reviewed and revised by an interdisciplinary team. The failure to accurately diagnose and document the resident's condition led to the inappropriate use of anti-psychotic medication, highlighting a significant deficiency in the facility's care planning and assessment processes.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.